The Zacks Analyst Blog Highlights: NIKE, Amgen, Morgan Stanley, Vertex Pharma and Moderna...…
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $241.31, moving +1.57% from the previous trading session....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $225.55, marking a -0.25% move from the previous day....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vertex Pharmaceuticals (VRTX) closed at $237 in the latest trading session, marking a +1.76% move from the prior day....…
Here we discuss five biotech stocks - EDIT, VRTX, NTLA, CBAY, MRNS - that could prove to be great investments…
Vertex Pharmaceuticals (VRTX) closed at $234.46 in the latest trading session, marking a -0.59% move from the prior day....…
Vertex (VRTX) signs a licensing agreement with privately held company Skyhawk Therapeutics to discover novel small molecules that modulate RNA…
The large biotech firm is just the latest deep-pocketed player to ink a heavily backloaded deal with the RNA-splicing specialist....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vertex Pharmaceuticals (VRTX) closed at $236.72 in the latest trading session, marking a -0.08% move from the prior day....…
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $224.17, moving +0.06% from the previous trading session....…
This high-flying biotech is trading on the cheap....…
Vertex (VRTX) gets European approval for label expansion of Symkevi and Kalydeco combination pill in cystic fibrosis patients aged six…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
8-K...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
CNBC's Brian Sullivan highlights the stocks seeing the most insider buying this week, on Worldwide Exchange, including names like Hanes…
Parini, Michael - Vorstand - Tag der Transaktion: 2020-11-04...…
Todays Daily Dose brings you news about FDAs briefing information related to Biogens Alzheimers drug candidate ahead of the panel…
ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Nov. 04, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) and…
What will the drugmaker do once it has the cystic fibrosis market cornered?...…
10-Q...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vertex (VRTX) beats estimates for both earnings and sales and raises revenue guidance for 2020....…
VRTX earnings call for the period ending September 30, 2020....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) decreased 1.4% in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share increased…
These two rare-disease drug developers are experts at penetrating their markets....…
The biotech sector was in focus as Biogens (BIIB) Q3 results disappoint, Vertex (VRTX) stops study and Regenerons (REGN) Ebola…
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity...…
Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co...…
Is (VRTX) Outperforming Other Medical Stocks This Year?...…
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as…
Vertex Pharmaceuticals (VRTX) closed at $220.51 in the latest trading session, marking a +1.11% move from the prior day....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär":
Thomas Bergmann, Redakteur beim Anlegermagazin "Der Aktionär", nimmt die Aktie des US-Biotechkonzerns Vertex…
Arrowhead Pharmaceuticals (NASDAQ: ARWR) shares are trading higher on Thursday on news that Vertex Pharmaceuticals discontinued its trial of a…
Vertex (VRTX) could produce exceptional returns because of its solid growth attributes....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Investors are concerned about Vertexs pipeline after a rare miss in the clinic....…
Todays Daily Dose brings you news about AnaptysBios generalized pustular psoriasis trial results, Cyclerion discontinuing its Sickle Cell Disease drug…
Vertex Pharmaceuticals Inc. VRTX stock fell in the extended session Wednesday after the biotech company said it would stop developing…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $276.09, marking a +0.54% move from the previous day....…